HSD3B7 and Cholestatic liver disease: There are few studies on HSD3B7, and most of them focus on patients with mutations of HSD3B7 developing a congenital BAs synthesis defect (CASD), which leads to a progressive cholestatic liver disease that is clinically responsive to primary BAs treatment.33